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Among the intestinal pathogenic Escherichia coli, enteroinvasive E. coli (EIEC) are a
group of intracellular pathogens able to enter epithelial cells of colon, multiplicate within
them, and move between adjacent cells with a mechanism similar to Shigella, the
ethiological agent of bacillary dysentery. Despite EIEC belong to the same pathotype
of Shigella, they neither have the full set of traits that define Shigella nor have undergone
the extensive gene decay observed in Shigella. Molecular analysis confirms that EIEC are
widely distributed among E. coli phylogenetic groups and correspond to bioserotypes
found in many E. coli serogroups. Like Shigella, also in EIEC the critical event toward
a pathogenic life-style consisted in the acquisition by horizontal gene transfer of a
large F-type plasmid (pINV) containing the genes required for invasion, intracellular
survival, and spreading through the intestinal mucosa. In Shigella, the ample gain in
virulence determinants has been counteracted by a substantial loss of functions that,
although important for the survival in the environment, are redundant or deleterious for
the life inside the host. The pathoadaptation process that has led Shigella to modify
its metabolic profile and increase its pathogenic potential is still in infancy in EIEC,
although maintenance of some features typical of E. coli might favor their emerging
relevance as intestinal pathogens worldwide, as documented by recent outbreaks in
industrialized countries. In this review, we will discuss the evolution of EIEC toward
Shigella-like invasive forms going through the epidemiology, including the emergence
of new virulent strains, their genome organization, and the complex interactions they
establish with the host.
Keywords: pathogenic E. coli, enteroinvasive E. coli (EIEC), Shigella, bacterial evolution, emerging EIEC
Abbreviations: DAMP, damage-associated molecular pattern; DEC, diarrheagenic E. coli; HGT, horizontal gene transfer;
H-NS, heat-stable nucleoid-structuring protein; IL, interleukin; IS, insertion sequence; MAPK, mitogen-activated protein
kinase; NLR, Nod-like receptor; PAI, pathogenicity island; PAMP, pathogen-associated molecular pattern; pINV, virulence
plasmid; PMNL, polymorphonuclear leukocytes; PRR, pattern recognition receptor; SHI, Shigella pathogenicity island; SRL,
Shigella resistance locus; sRNA, small RNA; T2SS, type II secretion system; T3SS, type III secretion system; TLR, Toll-like
receptor; TNF, tumor necrosis factor.
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INTRODUCTION
Escherichia coli is not only a harmless commensal of the human
and animal intestine but also a major cause of morbidity and
mortality (Kaper et al., 2004; Wirth et al., 2006). Indeed, many
pathogenic E. coli have been described as cause of diseases both
in healthy and immunocompromised individuals. Based on the
specific virulence factors and pathogenicity processes, pathogenic
E. coli have been subdivided into different pathogroups, that
can be broadly grouped as DEC (or intestinal) or extraintestinal
E. coli (ExPEC) (Kaper et al., 2004; Croxen and Finlay, 2009;
Gomes et al., 2016). DEC include at least six major pathotypes
differing in virulence mechanisms, infectious processes, and
damages provoked to the target cells: enteropathogenic E. coli
(EPEC), Shiga toxin-producing E. coli (STEC), enterotoxigenic
E. coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative
E. coli (EAEC), diffusely adherent E. coli (DAEC), as well as
adherent invasive E. coli (AIEC), a recently identified pathotype.
As for ExPEC, the most common strains belong to two
different pathotypes targeting different body compartments:
uropathogenic E. coli (UTI) and neonatal meningitis E. coli
(NMEC).
The presence of so many different pathotypes exemplifies the
remarkable plasticity of E. coli genome, which is characterized by
an extremely large pangenome of approximately 20,000 genes in
contrast to a common core of about 1700 genes (Rasko et al.,
2008; Touchon et al., 2009). Those that vary among different
pathogenic E. coli strains have been acquired by intense HGT and
are often conveyed by mobile genetic elements (Touchon et al.,
2009; Dobrindt et al., 2010; van Elsas et al., 2011).
Among the DEC pathotypes, EIEC are etiological agents
of bacillary dysentery in humans, particularly in low-income
countries (Croxen et al., 2013; Gomes et al., 2016). The
pathogenesis of EIEC infection is characterized by the ability
of bacteria to invade the human colonic mucosa, conferred by
the expression of chromosomal and plasmid-borne genes (Harris
et al., 1982; Sansonetti et al., 1982; Hale et al., 1983; Kaper
et al., 2004). Following penetration into colonic epithelial cells,
EIEC replicate intracellularly and spread to adjacent cells causing
the inflammatory destruction of the intestinal epithelial barrier.
This provokes the characteristic dysentery syndrome, usually self-
limiting, characterized by the presence of blood, mucus, and
leukocytes in stools (DuPont et al., 1971; O’Brien et al., 1979;
Taylor et al., 1988). The clinical illness caused by EIEC is similar
to that induced by Shigella spp. (Formal and Hornick, 1978; Small
and Falkow, 1988), with whom they are closely related in their
virulence and other phenotypic properties (Kopecko et al., 1985;
Lan et al., 2004). Notwithstanding the similarities in the invasion
mechanisms, the infectious dose of EIEC has been observed to be
much higher than that of Shigella and the diseases caused by EIEC
appear in some cases to be milder (DuPont et al., 1971).
Despite several studies, whether EIEC are precursors of the
“full blown” pathogen Shigella, or not is still under debate. In this
review, we will attempt at tracing the evolutionary pathway of
EIEC considering their epidemiology, the complex mechanisms
of their interaction with host cells, the key steps that could have
characterized their evolution from a commensal life style toward
pathogenicity, and the organization of their genome, including
the description of the major traits of emerging EIEC clones.
EPIDEMIOLOGY OF ENTEROINVASIVE
E. coli (EIEC)
The first report of an EIEC strain dates back at 1947 (Ewing
and Gravatti, 1947). At that time, it was defined as “paracolon
bacillus” but the strain was later identified as an O124 E. coli.
In the 1950s and 1960s, other E. coli strains, isolated from
dysentery and initially classified as Shigella manolovi, S. sofia,
Shigella strain 13, and S. metadysenteriae, due to their ability to
cause experimental keratoconjunctivitis in guinea pigs, were later
renamed as EIEC (Manolov, 1959; Rowe et al., 1977; Edwards and
Ewing, 1986). Their biochemical characters were first described in
1967 (Sakazaki et al., 1967; Trabulsi et al., 1967).
Enteroinvasive E. coli and Shigella spp. share several
phenotypic and genotypic characteristics, often making the
discrimination between the two genera challenging (Silva et al.,
1980; Toledo and Trabulsi, 1983; Bando et al., 1998; Lan and
Reeves, 2002; Pavlovic et al., 2011; van den Beld and Reubsaet,
2012), especially in case of shared serogroups. This difficulty
biases the interpretation of the epidemiological information
available, hindering the evaluation of the real burden of
EIEC infections. As a matter of fact, both EIEC and Shigella
spend much of their life cycle within the eukaryotic cells,
possessing the ability to use nutrients coming from the host
environment. Similarly to Shigella, most EIEC strains are unable
to decarboxylate lysine, lack the ability to ferment lactose, and are
generally non-motile, with the exception of strains belonging to a
few serogroups (Silva et al., 1980; Farmer et al., 1985; Bando et al.,
1998; Casalino et al., 2003; Tozzoli and Scheutz, 2014).
A limited set of serotypes have been assigned to EIEC, namely
O28ac:H-, O29:H-, O112ac:H-, O115:H-, O121:H-, O124:H-,
O124:H7, O124:H30, O124:H32, O135:H-, O136:H-, O143:H-,
O144:H-, O144:H25,O152:H-, O159:H-, O159:H2, O164:H-,
O167:H-, O167:H4, O167:H5, O173:H-, and recently O96:H19
(Voeroes et al., 1964; Silva et al., 1980; Gomes et al., 1987, 2016;
Orskov et al., 1991; Matsushita et al., 1993; Escher et al., 2014;
Tozzoli and Scheutz, 2014; Michelacci et al., 2016; Newitt et al.,
2016). Some of these EIEC-associated O antigens, such as O28,
O112ac, O121, O124, O143, O144, O152, and O167, are identical
to O antigens present in Shigella spp. (Cheasty and Rowe, 1983;
Tozzoli and Scheutz, 2014).
Enteroinvasive E. coli-infected humans seem to be the major
source of infection, as no animal reservoirs have been identified,
and transmission uses mainly the oral–fecal route. Although
EIEC infections occur worldwide, these are particularly common
in low-income countries where poor general hygiene favors their
spreading (Chatterjee and Sanyal, 1984; Beutin et al., 1997; Kaper
et al., 2004; Vieira et al., 2007).
Enteroinvasive E. coli incidence has been estimated in several
countries, and it differs depending on the region (Gomes et al.,
2016). Discrepancies among some of the reports can be observed,
probably due to the difficulty in discriminating between Shigella
and EIEC. In certain countries of Latin America and Asia,
Frontiers in Microbiology | www.frontiersin.org 2 December 2017 | Volume 8 | Article 2390
fmicb-08-02390 December 4, 2017 Time: 17:51 # 3
Pasqua et al. Evolution of Enteroinvasive E. coli
namely Chile, Thailand, India, and Brazil, EIEC were found to
be common diarrheagenic pathogens (Chatterjee and Sanyal,
1984; Faundez et al., 1988; Echeverria et al., 1992; Blake et al.,
1993; Levine et al., 1993), with frequent reports of asymptomatic
infected subjects excreting the pathogen (Beutin et al., 1997).
In industrialized countries, EIEC infections have been mainly
described as travel-related, being reported in returning travelers
from high-incidence countries (Wanger et al., 1988; Beutin et al.,
1997; Svenungsson et al., 2000). Occasionally, food and water
sources have been identified as vehicles of infection, but usually
as a secondary contamination by a human source (Tozzoli and
Scheutz, 2014).
Enteroinvasive E. coli cause sporadic cases of infection but
have been implicated in outbreaks as well, sometimes involving
large numbers of cases. In the 1970s a huge outbreak, affecting
387 patients and linked to cheese contaminated with an O124
E. coli strain, occurred in United States (Marier et al., 1973).
Recently, an increase of cases of infections linked to an emerging
EIEC clone has been observed in Europe, where in 2012 a
large and severe outbreak of bloody diarrhea in Italy involving
more than 100 individuals was reported (Escher et al., 2014;
Pettengill et al., 2015). An EIEC O96:H19 strain, a serotype
never described before for EIEC, was isolated and the suspected
source of infection was traced to cooked vegetables (Escher
et al., 2014). During the outbreak investigation an EIEC O96:H19
strain was also isolated from two asymptomatic food handlers
working in the canteen linked with the outbreak, supporting the
hypothesis of a secondary contamination of the vegetables during
post-cooking handling procedures (Escher et al., 2014). In 2014,
two linked outbreaks of gastrointestinal disease occurred in the
United Kingdom, involving more than 100 cases of infection.
One of the episodes was associated to the consumption of
contaminated salad vegetables and, again, an O96:H19 EIEC was
isolated from some of the patients and from vegetable samples
(Newitt et al., 2016). Finally, an EIEC belonging to the same
serotype was isolated in a case of traveler’s diarrhea in Spain in
2013 (Michelacci et al., 2016). Pheno-genotypic characterization
of the strains involved in the three episodes suggests that the EIEC
O96:H19 could be emerged as a result of the recent acquisition
of the invasion plasmid by an E. coli strain (Michelacci et al.,
2016).
THE INVASIVE PROCESS
Similarly to Shigella, EIEC are responsible of bacillary dysentery
(Taylor et al., 1988). However, the disease caused by EIEC
is usually less severe than that induced by Shigella (DuPont
et al., 1971). Following the discovery that EIEC strains carry a
pINV plasmid identical to that of Shigella (Harris et al., 1982;
Sansonetti et al., 1982; Hale et al., 1983) and that they can display
a Shigella-like invasive behavior (Hale et al., 1985; Small and
Falkow, 1988; Taylor et al., 1988), in vitro and in vivo studies
have been extensively focused on Shigella, providing in-depth
knowledge about its pathogenicity/virulence mechanisms. In
recent years, the pathogenicity of EIEC has gained new interest
and comparative analyses between EIEC and Shigella have been
performed, aimed at understanding the different clinical outcome
severity of the two infections (Moreno et al., 2009; Bando et al.,
2010; Sanchez-Villamil et al., 2016). Here we first present the
invasive process as it has been inferred from studies on S. flexneri.
Then, we address what it is known about the difference between
these two enteroinvasive bacteria.
In order to gain access to intestinal epithelia, bacteria first
transit from the lumen to the submucosa by preferentially
entering M cells in Peyer’s patches. After endocytosis by M cells
bacteria are transcytosed toward the M cell pocket, where they
meet, and are phagocytosed by resident macrophages. Shigella
infection of macrophages is accompanied by the release of
T3SS effectors and components that are recognized as PAMPs
by NLRs, ultimately leading to pyroptosis with the release of
proinflammatory cytokines, IL-1β and IL-18 (Ashida et al., 2011).
The induction of macrophage cell death is pivotal for bacteria
to invade enterocytes, though pyroptosis is a form of cell death
that induces a massive inflammatory response. Once released
from dying macrophages, invasive bacteria infect the neighboring
enterocytes by entering through the basolateral surface. Here
they are enclosed into a vacuole that is rapidly disrupted freeing
them into the cytosol. Subsequently, the bacteria multiply and,
using actin-based motility, spread to adjacent cells (Schroeder
and Hilbi, 2008).
Inside epithelial cells, bacterial PAMPs and DAMPs are
detected by various PRRs, including TLRs and NLRs, which
stimulate host defense signal pathways such as those involving
MAPKs and NF-κB leading to the secretion of proinflammatory
cytokines (e.g., IL-8 and TNF-α) (Takeuchi and Akira, 2010).
These molecules induce the recruitment of phagocytic cells
to the infection site, initially facilitating the invasion process
and eventually clearing the bacterial pathogens. In order to
maximize invasion and permanence and save the replicative
niche in epithelial cells, invading Shigella modulate host cell
responses throughout the infection process by secreted effectors
(Killackey et al., 2016). Induction of a very early inflammatory
response upon invasion of epithelial cells is functional to bacterial
spreading as it results in recruitment of polymorphonuclear
leucocytes (PMNL), which migrate across the epithelium
destabilizing the intercellular junctions and increasing the surface
available for bacterial entry into target cells (Ashida et al.,
2011). Several T3SS effectors, such as OspB, OspC1, and OspZ
(Zurawski et al., 2009; Ambrosi et al., 2015; Mattock and Blocker,
2017), contribute to promote inflammation at early stages of the
infection process. They mainly act by enhancing activation of
MAPK and NF-κB pathways, which are involved in the control
of the production of PMNL chemoattractants, including IL-8,
whose secretion triggers PMNL migration in a basolateral to
apical direction causing epithelial barrier disruption. However,
though this early inflammatory response is essential to initiate
infection, it would also contribute toward rapidly clearing the
infecting agents. Thus, to establish infection, at later stages
Shigella must overcome the host innate response. This is achieved
by delivering T3SS effectors, whose function is aimed mainly
at inhibiting MAPK and NF-κB signaling pathways with the
consequent decrease of inflammatory chemokine and cytokine
production (Killackey et al., 2016; Mattock and Blocker, 2017).
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An important obstacle Shigella must tackle during the invasion
of the epithelial tissue is host cell targeting and degradation
by autophagy. Several studies have demonstrated that Shigella
are particularly exposed to autophagy targeting only when
they are associated to cell membranes. Two bacterial factors,
IcsB and VirA, have been implicated in bacterial evasion of
autophagy targeting by interfering with LC3 recruitment and by
allowing bacteria to escape from LC3-positive vacuoles (Ogawa
et al., 2005; Baxt and Goldberg, 2014; Campbell-Valois et al.,
2015).
Typically, intracellular pathogens need to save their host
to establish a successful infection. As part of their pathogenic
mechanism Shigella employ several countermeasures to avoid
premature cell death to maintain their epithelial replicative niche.
The early stage of infection is characterized by induction of DNA
damage and genotoxic stress, which lead to activation of p53 and
stimulation of apoptosis. Apoptotic cell death is prevented by
the activity of the T3SS effectors VirA and IpgD, which promote
p53 degradation and activate the PI3K/Akt pro-survival pathway,
respectively, and by the pilus component protein FimA, which
inhibits cytochrome c release by mitochondria (Mattock and
Blocker, 2017).
As discussed above, EIEC share many aspects of the
Shigella infection process that involves crossing of intestinal
epithelial barrier, killing of resident macrophage cells, invasion
of enterocytes, intra-cellular replication, and dissemination from
cell to cell without extracellular steps (Croxen and Finlay, 2009).
Moreover, EIEC express the same virulence factors found in
Shigella (Parsot, 2005). However, the infectious dose required
for EIEC to cause disease is higher than that of Shigella and
the disease caused by EIEC appears to be milder (DuPont
et al., 1971), suggesting differences between EIEC and Shigella
in sensing and shaping the host environment, which, in turn,
would influence the pathways toward virulence. To date only
few studies have investigated the differences in the infectiveness
between EIEC and Shigella. Moreno et al. (2009) detailed for
the first time the relationship between the expression of some
genes crucial for the infection process and the reduced ability
of EIEC to cause disease. This is well supported by their Serény
tests in guinea pigs, showing how the signs of keratoconjunctivitis
induced by Shigella appear earlier and are more severe as
compared to those caused by EIEC. Using an epithelial cell
model, the authors also demonstrate that, although Shigella
and EIEC display similar invasion ability, EIEC disseminates
less efficiently, producing smaller plaques in plaque assays. As
compared to Shigella the overall behavior of EIEC apparently
reflects a reduced expression of key virulence genes, during
both invasion and cell-to-cell spreading, except for virF that is
expressed at higher levels by intracellular EIEC than Shigella
during the dissemination step. This apparent discrepancy may
be explained in the light of recent results showing that Shigella
virF is transcribed into two mRNAs, with the shortest one
encoding a smaller protein that negatively regulates transcription
of full-length mRNA and, consequently, the expression of the
VirF regulator (Di Martino et al., 2016b). Since in the real-
time PCR experiments carried out by Moreno et al. (2009) virF
expression was assayed by using primers that did not discriminate
between the two mRNAs, comparative virF expression studies
between Shigella and EIEC deserve further investigations to
deeper analyze potential differences.
A more recent work has compared the host cell response
to infection by different E. coli pathotypes, including EIEC,
and by Shigella. The kinetic of NF-κB and ERK1/2 activation
in HT-29 epithelial cells shows only a slightly higher p65
phosphorylation after 4 h of infection with Shigella as compared
with EIEC. Conversely, although following a similar kinetics,
the accumulation of phosphorylated ERK1/2 is much higher
in cells infected with EIEC at 4 h post-infection. Despite
these differences, HT-29 cells infected with EIEC or Shigella
release comparable amounts of cytokines, as IL-8 and TNF-α
with similar kinetics (Sanchez-Villamil et al., 2016). The
phosphorylation of ERK1/2 and p38 is controlled by the
phosphothreonine lyase activity of OspF, to which both anti-
inflammatory (Arbibe et al., 2007) and pro-inflammatory roles
(Reiterer et al., 2011) have been attributed. Since both Shigella
and EIEC express OspF, it is reasonable that additional factors are
involved in determining the different ERK1/2 phosphorylation
profile and the outcome of MAPK activation.
The key step in invasion of the epithelial cells resides in
the ability of EIEC and Shigella to escape from macrophages
after phagocytosis by induction of caspase 1-dependent cell
death. It has been reported that, as compared to Shigella,
EIEC have a decreased capacity to escape from murine J774
macrophages and are less efficient in cell killing during the
first 4 h of infection (Bando et al., 2010). This likely depends
on differences in the expression of some virulence genes.
In particular, as compared to Shigella the expression of the
ipaC gene is reduced in intracellular EIEC at all the time
points after infection. As for the release of pro- and anti-
inflammatory cytokines (as TNF-α, IL-1, and IL-10) by infected
cells, contrasting results exist. While no significant differences
between EIEC and Shigella-infected J774 cells (Bando et al.,
2010) have been reported, other studies carried out using human
THP-1 cells differentiated into macrophages (Sanchez-Villamil
et al., 2016) have shown that Shigella infection results in higher
secretion of both pro-inflammatory and anti-inflammatory
cytokines.
To date, banking on the modest amount of data available
from in vitro infection of macrophage-like cells and epithelial
cells, the milder disease caused by EIEC appears to be
mainly associated to a lower expression of key virulence
genes involved in phagosomal escape inside host cells and
in dissemination among epithelial cells (Moreno et al., 2009;
Bando et al., 2010). There are no obvious differences in the
inflammatory response by epithelial cells, at least as far as the
secretion of IL-8 and TNF-α is concerned, neither at early
nor at late times of infection. Despite this cytokine profile,
the activation state of ERK1/2 MAPK seems to be more
elevated in epithelial cells infected with EIEC than in those
infected with Shigella (Sanchez-Villamil et al., 2016). Deeper
investigations will clarify to what extent this may depend
on differences in manipulating certain cell signaling pathways
and on differences in the activity of bacterial factors involved
therein.
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THE MAJOR VIRULENCE TRAIT OF
EIEC: THE LARGE VIRULENCE PLASMID
pINV
The evolution of E. coli toward pathogenic phenotypes has been
determined, as in many other bacterial pathogens, mainly by
two mechanisms: the acquisition of virulence genes by HGT
as parts of plasmids, phages, transposons, or PAI and the loss
or modification of genes of the core genome. While the first
mechanism plays a crucial role in the colonization of a new
host environment, the latter, known as pathoadaptation, strongly
contributes to drive the evolution of bacteria toward a more
pathogenic phenotype (Kaper et al., 2004; Dobrindt et al., 2010).
It is widely acknowledged that, as in Shigella, in EIEC the
critical event in the transition toward a pathogenic lifestyle has
been the acquisition of a large F-type plasmid (pINV) which
encodes the molecular machinery required for invasion, survival,
and diffusion of the bacterium within the host (Harris et al.,
1982; Sansonetti et al., 1982; Hale et al., 1983; Small and Falkow,
1988; Figure 1). The pINV plasmid has been found only in the
Shigella/EIEC pathotype and its loss is a very rare event, which
determines an avirulent phenotype.
The genetic organization of the pINV is very complex
(Johnson and Nolan, 2009). As a matter of fact these plasmids are
FIGURE 1 | Genetic map of the pINV of Shigella and EIEC strains. The red
arrows indicate major virulence determinants. Due to the variability in position
and number, the ipaH genes are not shown. The genetic organization of the
entry region is shown in detail, with dashed arrow lines indicating known
transcriptional units. The entry region organization is based on the sequence
of plasmid pWR100 (Venkatesan et al., 2001) while the entire plasmid is freely
drawn to provide the layout of a typical pINV plasmid (the figure is not to
scale).
made up of a mosaic of genes of various origins and harbor traces
of four different plasmids (Buchrieser et al., 2000; Venkatesan
et al., 2001; Escobar-Páramo et al., 2003). pINV isolated from
EIEC share wide regions of high structural and functional
homology and are interchangeable with those isolated from
Shigella strains (Hale et al., 1983; Lan et al., 2001; Johnson and
Nolan, 2009). pINV share with IncFIIA plasmids high homology
in the regions involved in replication (rep) and conjugation (tra)
(Makino et al., 1988) and stable inheritance of pINV is ensured
by the presence of several plasmid segregation and maintenance
systems (Lan et al., 2001). Due to large deletions in the tra region,
pINV are not capable of self-transfer by conjugation, but they can
be mobilized by other conjugative plasmids. All over the plasmid
genome, an astonishing number of ISs is present as a mixture
of complete and incomplete IS elements repeated several times,
confirming the relevant role played by ISs in pINV assembly and
evolution (Buchrieser et al., 2000; Venkatesan et al., 2001). Most
ISs are related to known elements while others represent novel
ISs. Among the latter, ISEc11, an IS belonging to the IS1111
family, is widespread and functional in pINV from EIEC while
only defective copies are present in the Shigella pINV plasmids
(Prosseda et al., 2006).
In the pINV there is only one large (31 kb) region, which
does not host any IS elements. This is the so-called entry
region, which displays a PAI-like structure (Buchrieser et al.,
2000; Venkatesan et al., 2001). It is composed by two large,
divergently transcribed gene clusters coding for a T3SS apparatus
(Mxi and Spa), for most of its effectors (IpaB, IpaC, and IpaD)
with their chaperons (IpgA, IpgC, IpgE, and Spa15), and for
two transcriptional regulators (VirB and MxiE), both required
for the activation of most virulence genes (Schroeder and Hilbi,
2008; Figure 1). The entry region is extremely conserved among
Shigella and EIEC pINV plasmids (Lan et al., 2001). Albeit it
had been initially proposed as a PAI, likely acquired in a single
recombination event, it lacks the presence of flanking tRNA
sequences and at least remnants of a recombinase-encoding
gene. It is therefore unclear if the acquisition of the entry
region has occurred independently from its insertion into tRNA
sequences or if the absence of tRNA genes may have resulted from
rearrangement following gene transfer. The latter hypothesis
is supported by the fact that the entry region is flanked by
truncated IS elements, suggesting that rearrangements may have
occurred after its acquisition en bloc by the plasmid (Buchrieser
et al., 2000). The T3SS encoded by the entry region plays a
critical role in the bacterial invasive process, since it delivers
a large number of effectors involved in the reorganization of
the host cell actin cytoskeleton and in the modulation of cell
signaling pathways to evade the host immune response (Mattock
and Blocker, 2017). With the exception of few proteins of
the IpaH family, which are chromosomally encoded, all T3SS
effectors are encoded by pINV genes located within or outside
the entry region. Since the entry region is highly conserved,
the phylogenetic analysis of three of its genes (ipgD, mxiC,
and mxiA) has allowed differentiating pINV from Shigella
spp. and EIEC into two forms, A and B, with the first one
predominantly associated with EIEC strains (Lan et al., 2001,
2004).
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Besides the large PAI-like region, a small islet carries the genes
coding for IcsA (a protein responsible for the bacterial motility
inside the cytoplasm), VirA (a GTPase-activating protein), and
RnaG (a regulatory sRNA negatively controlling icsA expression)
(Giangrossi et al., 2010; Tran et al., 2011; Dong et al., 2012).
Other genes encoding proteins crucial for the invasive process
cover the pINV plasmid including the OspG and OspF proteins
which interfere with the host innate immune response (Kim
et al., 2005; Arbibe et al., 2007), the PhoN2 protein required for
IcsA localization (Scribano et al., 2014), and the IpaH proteins
which interfere with the host protein degradation (Ashida and
Sasakawa, 2015; Figure 1). Moreover, in contrast to the other
two virulence regulatory genes (virB and mxiE), the virF gene,
coding for the primary virulence regulator, is located on a
“desert island” surrounded by several IS sequences and far away
from all other virulence genes, including those under its direct
control, virB and icsA (Di Martino et al., 2016a). While the CG
content of virF is only slightly lower as compared to that of the
entry region (Buchrieser et al., 2000), its position suggests that
it has been acquired independently to promote the expression
of the virulence genes. VirF is also involved in the activation
of some chromosomal genes, indicating that it acts as global
regulator and that its acquisition by HGT has contributed to a
reshaping of the core genome, easing the adaptation of bacteria
to the host environment (Barbagallo et al., 2011; Leuzzi et al.,
2015).
The mechanisms involved in the activation of the pINV
virulence genes have been extensively studied both in EIEC
and in Shigella (Dagberg and Uhlin, 1992; Prosseda et al.,
2002). They rely on a sophisticated regulatory cascade involving
global and specific regulators, encoded by both, pINV and
the chromosome. Outside the human host, the nucleoid-
associated protein H-NS represses each of the key promoters
of the pINV virulence genes (Dorman, 2004). In response to
environmental conditions found in the human intestine, the
transcriptional activation of the invasive operons is triggered
by an increased level of VirF counteracting H-NS repression
at the icsA and virB promoters (Prosseda et al., 2004). Then
VirB activates most operons within the entry region, including
the gene for the last regulator (mxiE), as well as all other
virulence genes scattered along the pINV genome, except icsA.
Finally, MxiE, assisted by IpgC, activates the transcription
of genes encoding the late effectors (Schroeder and Hilbi,
2008).
As in other pathogenic E. coli, also in EIEC the virulence
genes are stably maintained on an extrachromosomal element
(Johnson and Nolan, 2009). Nevertheless, it has been reported
that the pINV of EIEC strain HN280 is able to integrate into
the host chromosome and that integration results in silencing of
all pINV-encoded virulence genes also under host temperature
conditions (Zagaglia et al., 1991). Silencing was shown to depend
on a severe reduction of virB transcription, likely dependent on
the inability of VirF to counteract the negative control of H-NS at
the virB promoter when it is chromosomally located (Colonna
et al., 1995). This has led to the hypothesis that the presence
of virulence genes on the pINV is the result of an evolutionary
pathway toward the optimization of gene expression.
EVOLUTION OF EIEC
The studies on the evolutionary origin of the Shigella/EIEC
pathovar have led to two major hypotheses. The pINV could
have been acquired only once by an ancestral E. coli that
subsequently gave rise to the different Shigella/EIEC lineages
(Escobar-Páramo et al., 2003; Zuo et al., 2013), as suggested by
the inability of the plasmid to autonomously undergo horizontal
transmission. Alternatively, the different Shigella/EIEC strains
could have arisen from different E. coli that had acquired the
pINV independently, e.g., from an unknown donor or from other
Shigella/EIEC that already harbored it. This view is supported by
the diversity of the genotypes within the Shigella/EIEC pathovar,
revealed by phylogenetic analyses of chromosomal genes and
by genome comparison (Pupo et al., 2000; Hazen et al., 2016;
Pettengill et al., 2016). Besides the large pINV, several virulence
genes have been acquired on the chromosome of Shigella and
EIEC as part of PAIs (Figure 2). The PAIs described so far
for Shigella (SHI islands) carry genes encoding different traits,
including an enterotoxin and a cytotoxic protease (SHI-1) and
systems involved in iron uptake and evasion of immune response
(SHI-2 and SHI-3 in S. boydii), in the modification of O antigens
(SHI-O) or in multi-drug resistance (SRL) (Schroeder and Hilbi,
2008). Recently, 20 genomes from EIEC belonging to different
serotypes have been compared with those of reference strains
belonging to diverse E. coli pathovars and Shigella species. This
comparison highlights the existence of at least three distinct
lineages containing only EIEC strains and suggests a convergent
evolution of non-pathogenic E. coli toward invasive phenotype
(Hazen et al., 2016). An in silico search for protein-encoding
genes of SHI-1, SHI-2, SHI-3, SHI-O, and SRL indicates that, with
FIGURE 2 | Genetic events contributing to the evolution of EIEC from
ancestral commensal E. coli. The acquisition of the pINV by HGT is a major
evolutionary event toward pathogenicity. This can be accompanied by the
sporadic acquisition of entire or incomplete SHI-1 PAI and incomplete SHI-2
and SHI-3 PAIs. Rarely, also incomplete SRL PAI are acquired by EIEC
genomes. The absence of ompT and the loss of cadaverine synthesis (usually
resulting from cadC silencing) counterbalance the gain of virulence-associated
determinants. The inactivation of speG (involved in spermidine acetylation) and
nad (involved in NAD biosynthesis) is regarded as emergent pathoadaptive
mutations in EIEC.
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the exception of SHI-O, portions of the other PAIs are present in
EIEC genomes in a lineage-specific manner (Hazen et al., 2016).
Interestingly, while a whole SHI-1 Island has never been detected
in EIEC, SHI-1 fragments of different length have been found
in all EIEC genomes. However, the ShET1 toxin genes, typically
harbored by SHI-1 in S. flexneri genomes, were found only in
EIEC strains of lineage 2. In the case of virulence genes associated
with SHI-2, the shiA gene, involved in the reduction of the host
inflammatory response, is absent in all EIEC lineages, while shiD,
which provides immunity to colicins, is present in all EIEC of
lineages 1 and 2. An entire SHI-3 PAI, typically associated with
S. boydii strains, has been detected only in few EIEC strains
of lineages 1 and 2, while portions of it, including the genes
encoding for aerobactin-mediated iron uptake, are found in all
three lineages. As for the large SRL PAI, widely distributed among
Shigella spp. and containing a cluster of multiple antibiotic
resistance determinants (Turner et al., 2003), only a few of its
genes are present in EIEC genomes.
The variable presence of the PAIs in EIEC confirms the
phylogenetic diversity among EIEC and Shigella and further
supports the hypothesis that the EIEC pathovar has not a single
origin but rather stems from multiple lineages (Hazen et al., 2016;
Michelacci et al., 2016; Pettengill et al., 2016).
A significant complementary step toward the pathogenic
lifestyle has been pathoadaptation, the inactivation, or loss of
several chromosomal genes, which negatively interfere with
the expression of virulence factors required for survival within
the host. The antivirulence loci identified encode a broad
spectrum of functions, confirming that adaptation to the new
host environments is the result of long and ordered process
targeting core genome determinants (Casalino et al., 2003; Di
Martino et al., 2013b; Campilongo et al., 2014).
Despite the close similarity of the Shigella and EIEC
pathogenicity process, it is well known that EIEC have a
metabolic activity more similar to E. coli and have not undergone
the intense gene decay observed in Shigella (Silva et al., 1980;
Pettengill et al., 2016). It is therefore not surprising that the
pathoadaptation in EIEC has not reached a level comparable
to Shigella (Prosseda et al., 2012) and that most of the
antivirulence loci characterized in Shigella are still encoding
functional products in EIEC. One of the pathoadaptive mutations
conserved both in EIEC and in Shigella is the deletion of the ompT
gene, located within the defective lambdoid prophage DLP12
(Nakata et al., 1993; Figure 2). The OmpT protease triggers the
degradation of IcsA protein and therefore negatively interferes
with host cell invasion by drastically reducing the ability of
Shigella to spread into adjacent epithelial cells. Considering that
the loss of OmpT is widespread, it is as yet unclear if E. coli
lineages that gave rise to the Shigella/EIEC pathovar have not
hosted DLP12 ab initio or if the prophage has been excised during
the pathoadaption process (Bliven and Maurelli, 2012; Leuzzi
et al., 2017).
Another typical pathoadaptive mutation of Shigella spp.
is the inability to catabolise lysine, due to the silencing of
lysine decarboxylase (LDC) activity (Prosseda et al., 2007).
The LDC− phenotype, which is found also in most EIEC, is
determined by mutations in the cad locus, which hamper the
synthesis of cadaverine. Cadaverine is a polyamine that interferes
with pathogenicity by blocking the release of Shigella into the
cytoplasm of the infected cells and inhibiting the migration of
PMNL across the intestinal epithelium (Bliven and Maurelli,
2012). A detailed analysis of the molecular rearrangements
occurred in the cad operon of several EIEC strains belonging
to different serotypes (Casalino et al., 2003) has shown that,
similarly to Shigella, the silencing of the cad locus has been
accomplished through convergent evolution. In contrast to
Shigella, in EIEC the cad region is colinear with the E. coli K12
chromosome and the lack of cadaverine synthesis is mainly due
to the inactivation of the gene encoding the CadC transcriptional
regulator (Casalino et al., 2010). By comparing the cad loci of
EIEC and Shigella, it appears that the rearrangements occurred
in EIEC are less severe compared to the complete erosion of the
locus observed in several Shigella strains (Casalino et al., 2005;
Prosseda et al., 2007; Figure 2). Indeed, despite the antivirulence
role played by cadaverine (Fernandez et al., 2001), emerging
O96:H19 EIEC strains still maintains an integer cad operon and
exhibits a LDC+ phenotype (Michelacci et al., 2016).
As compared to the commensal E. coli the polyamine profile
of Shigella is affected not only by the lack of cadaverine but also
by the marked accumulation of spermidine and by the loss of
N-acetyl spermidine, the inert form of spermidine (Di Martino
et al., 2013a). The increased spermidine content depends on
the loss of the spermidine acetyltransferase (SAT), the enzyme
encoded by the speG gene and responsible for the conversion
of spermidine into N-acetylspermidine. In Shigella it has been
demonstrated that a higher level of spermidine increases survival
within macrophages and confers bacteria a higher resistance
to oxidative stress (Barbagallo et al., 2011). Similarly to how
observed for the cad locus, also speG silencing is the result of
convergent evolution. A comparison of the polyamine profiles of
several EIEC strains with those of Shigella and E. coli K12 has
revealed that in EIEC major polyamines attain levels in-between
those observed in E. coli and Shigella. Indeed, as compared to
commensal E. coli, in EIEC intracellular putrescine is significantly
increased and spermidine tends to be higher. Nevertheless, in
contrast to Shigella, N-acetylspermidine is still present in most
EIEC strains (Campilongo et al., 2014), indicating that the
loss of speG is an emerging trait. However, when spermidine
accumulation is induced in EIEC through deletion of the speG
gene, survival within macrophages, as well as resistance to
oxidative stress are increased (Campilongo et al., 2014). This
confirms that the absence of SAT activity confers to intracellular
bacteria like EIEC and Shigella an increased capability to
defy antagonistic host environment. Moreover, the analysis of
the polyamine profiles has revealed that the higher level of
putrescine in EIEC is determined by increased transcription
of speC, promoted by the lack of cadaverine. The speC gene
encodes the enzyme converting L-ornithine into putrescine.
On the basis of these observations it has been suggested
(Campilongo et al., 2014) that during the transition toward
the pathogenic phenotype, the modification of the polyamine
profile might have been triggered by the loss of cadaverine,
with the double effect of favoring the invasive process and
increasing the putrescine level. Since putrescine is an important
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intermediate in the synthesis of spermidine and, consequently, of
N-acetylspermidine, its increase may in turn have caused higher
levels of both polyamines. In this scenario the silencing of speG,
which appears completed in Shigella but can be regarded as an
ongoing process in EIEC, would represent the last step favoring
further accumulation of spermidine and the disappearance of
N-acetylspermidine.
Another noteworthy pathoadaptive mutation in Shigella is
the requirement for exogenous nicotinic acid (NAD) due to
inactivation of the nad genes (Prunier et al., 2007), required
for de novo synthesis of NAD. Also in this case the inability to
synthesize NAD is not a generalized feature among EIEC strains
(Di Martino et al., 2013b). In those EIEC strains requiring NAD it
has been shown that the preferential target in the pathoadaptation
process is the nadB gene, inactivated through diverse strategies,
involving point mutations or IS insertions.
Altogether, the picture emerging from the observations on
pathoadaptive mutations suggests that EIEC might represent
intermediates in the evolution toward a full-blown phenotype,
with some mutational events still confined to Shigella (Figure 2).
However, a recent whole-genome comparative analysis
(Pettengill et al., 2016), performed on a large number of
Shigella and EIEC genomes, indicates that Shigella and EIEC
evolved independently. Nevertheless, the same authors proposed
that, while EIEC as a group cannot be considered the ancestor
to Shigella, some EIEC lineages might have been the Shigella
ancestor.
EMERGING ENTEROINVASIVE
Escherichia coli
The recent outbreaks occurred in Europe caused by the EIEC
O96:H19 led the scientific community to reconsider the role of
EIEC infection in industrialized countries (Escher et al., 2014;
Michelacci et al., 2016; Newitt et al., 2016). Such EIEC serotype
had never been reported before 2012 and represents a new
virulent emergent clone. The EIEC O96:H19 isolated from two
outbreaks occurred in Italy and United Kingdom and from
a sporadic case of disease reported in Spain were studied by
whole genome sequencing (Pettengill et al., 2015; Michelacci
et al., 2016). The genomic analysis confirmed that all the isolates
belonged not only to the same unprecedented EIEC serotype,
but also to the same sequence type (ST-99), never observed
before in EIEC strains (Michelacci et al., 2016). The analysis of
the distribution of virulence genes typical of EIEC and Shigella
highlighted the presence in the three strains of the plasmid
genes encoding the T3SS system and its effectors, as well as the
master transcriptional regulators genes virF and virB. As for the
chromosomally located virulence genes, the three isolates showed
the presence of the genetic determinants of a T2SS and were
all negative for those encoding the aerobactin system involved
in iron uptake. Interestingly, none of the O96:H19 isolates was
found to have undergone the process of pathoadaptation through
accumulation of the mutations described in the literature for
EIEC and Shigella (Bliven and Maurelli, 2012; Prosseda et al.,
2012). Nevertheless, the three isolates were shown to display
minor differences. The plasmid profiles obtained through the
genomic analysis highlighted the presence of five plasmids in the
strains isolated in Spain and United Kingdom and three plasmids
in that responsible of the Italian outbreak, with three plasmids
in common in the three strains. Altogether, these observations
strengthen the hypothesis of the emergence of a new virulent
EIEC clone circulating in Europe.
Phenotypic analysis also highlighted peculiar properties of
this EIEC clone, when compared to reference EIEC and Shigella
strains. Biochemical characterization showed that the isolates
displayed the LDC activity, confirming the lack of the related
pathoadaptive mutations observed through genome analysis,
and interestingly showed that the isolates retained the ability
to ferment lactose (Michelacci et al., 2016), usually lacking in
Shigella and in the majority of EIEC strains (Tozzoli and Scheutz,
2014). Generally, a better fitness was observed for the O96:H19
strains when comparing the growth curves with those of Shigella
and reference EIEC strains (Michelacci et al., 2016). Moreover,
swimming motility was observed for the strains from Italian
and Spanish cases, which was instead completely absent in the
strain from United Kingdom and in all the other EIEC and
Shigella strains tested. Such phenotypic traits are not typical of
intracellular pathogens such as EIEC and Shigella, while they are
more common in E. coli strains, contributing to their great ability
in surviving and adapting in different ecological niches.
These findings support the hypothesis of the evolution of
EIEC and Shigella after the acquisition of the pINV by multiple
lineages of commensal E. coli, followed by a multi-step adaptation
process. Such an evolutionary pathway could be exemplified by
EIEC ST-280 Clonal Complex, which could have been generated
with the acquisition of the pINV plasmid by a commensal E. coli
eventually evolving toward Shigella belonging to related clonal
complexes (ST-149, 152, 243, 245, 250) (Wirth et al., 2006;
Michelacci et al., 2016). The mechanism could have involved
multiple events of pathoadaptive mutations, giving origin to the
existing Shigella clones, specialized for intracellular survival with
detriment of the ability to persist outside the host. A similar
paradigm could also explain the emergence of other EIEC clones
following the acquisition of pINV by other commensal E. coli.
This event in some cases could be followed by the accumulation
of pathoadaptive mutation, as it is the case of the EIEC strains
belonging to ST-6 clonal complex, while some other clones
could have maintained all the functions granting an efficient
extracellular persistence, such as the EIEC O96:H19 belonging
to ST-99 (Michelacci et al., 2016). The observed better fitness of
EIEC O96:H19 in comparison with that of the other reference
EIEC and Shigella strains could have favored its survival in the
extracellular environment and allowed its overgrowth in the food
vehicles, granting it a high potential as a foodborne pathogen,
as demonstrated in the two large episodes occurred in Italy and
United Kingdom (Michelacci et al., 2016; Newitt et al., 2016).
CONCLUSION AND PERSPECTIVES
Genomics approaches in combination with phenotypic analyses
have a strong potential toward the formulation of new intriguing
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hypotheses on the ongoing evolution of EIEC. Currently available
comparisons between EIEC and Shigella genomes support the
need for a taxonomical revision moving the Shigella genus back
within the E. coli species (Michelacci et al., 2016; Pettengill
et al., 2016). As a matter of fact, Shigella clades are interspersed
in clusters of E. coli genomes regardless of the bioinformatics
approach used for the phylogenetic analysis (Sahl et al., 2015;
Pettengill et al., 2016). In the light of recent studies, the
organization of the EIEC genome appears to have been originated
from multiple independent events (Hazen et al., 2016; Pettengill
et al., 2016). This hypothesis finds even stronger evidence in
the emergence of a novel EIEC clone belonging to O96:H19
serotype, which exhibits phenotypic traits more typical of
E. coli than of reference EIEC or Shigella (Michelacci et al.,
2016).
The acquisition of the plasmid may represent the first step
in the emergence of new EIEC clones, but it is well known
to be not sufficient for establishing the full pathogenicity
(Sansonetti et al., 1983). In this context, it is of great
interest to deeper investigate on the role and relevance
of functions that Shigella has lost in its route toward an
intracellular life-style but that are still retained by most EIEC
strains.
AUTHOR CONTRIBUTIONS
BC, VM, SM, and GP proposed the idea of the review; MP, VM,
MG, and RT wrote the review draft; MP, MM, and GP design
the figures; BC, MM, GP, MG, and SM wrote the final version
of the review. The final text has been read and approved by all the
authors of the review.
FUNDING
This research was supported by grants from Sapienza Università
di Roma and from Institut Pasteur (PTR-24-16).
REFERENCES
Ambrosi, C., Pompili, M., Scribano, D., Limongi, D., Petrucca, A.,
Cannavacciuolo, S., et al. (2015). The Shigella flexneri OspB effector:
an early immunomodulator. Int. J. Med. Microbiol. 305, 75–84.
doi: 10.1016/j.ijmm.2014.11.004
Arbibe, L., Kim, D. W., Batsche, E., Pedron, T., Mateescu, B., Muchardt, C., et al.
(2007). An injected bacterial effector targets chromatin access for transcription
factor NF-κB to alter transcription of host genes involved in immune responses.
Nat. Immunol. 8, 47–56. doi: 10.1038/ni1423
Ashida, H., Ogawa, M., Kim, M., Suzuki, S., Sanada, T., Punginelli, C., et al.
(2011). Shigella deploy multiple countermeasures against host innate immune
responses. Curr. Opin. Microbiol. 14, 16–23. doi: 10.1016/j.mib.2010.08.014
Ashida, H., and Sasakawa, C. (2015). Shigella IpaH family effectors as a versatile
model for studying pathogenic bacteria. Front. Cell. Infect. Microbiol. 5:100.
doi: 10.3389/fcimb.2015.00100
Bando, S. Y., do Valle, G. R., Martinez, M. B., Trabulsi, L. R., and Moreira-Filho,
C. A. (1998). Characterization of enteroinvasive Escherichia coli and Shigella
strains by RAPD analysis. FEMS Microbiol. Lett. 165, 159–165. doi: 10.1111/j.
1574-6968.1998.tb13141.x
Bando, S. Y., Moreno, A. C. R., Albuquerque, J. A. T., Amhaz, J. M. K., Moreira-
Filho, C. A., and Martinez, M. B. (2010). Expression of bacterial virulence
factors and cytokines during in vitro macrophage infection by enteroinvasive
Escherichia coli and Shigella flexneri: a comparative study. Mem. Inst. Oswaldo
Cruz 105, 786–791. doi: 10.1590/S0074-02762010000600009
Barbagallo, M., Di Martino, M. L., Marcocci, L., Pietrangeli, P., De Carolis, E.,
Casalino, M., et al. (2011). A new piece of the Shigella pathogenicity puzzle:
spermidine accumulation by silencing of the speG gene [corrected]. PLOS ONE
6:e27226. doi: 10.1371/journal.pone.0027226
Baxt, L. A., and Goldberg, M. B. (2014). Host and bacterial proteins that repress
recruitment of LC3 to Shigella early during infection. PLOS ONE 9:e94653.
doi: 10.1371/journal.pone.0094653
Beutin, L., Gleier, K., Kontny, I., Echeverria, P., and Scheutz, F. (1997). Origin and
characteristics of enteroinvasive strains of Escherichia coli (EIEC) isolated in
Germany. Epidemiol. Infect. 118, 199–205. doi: 10.1017/S0950268897007413
Blake, P. A., Ramos, S., MacDonald, K. L., Rassi, V., Gomes, T. A., Ivey, C., et al.
(1993). Pathogen-specific risk factors and protective factors for acute diarrheal
disease in urban Brazilian infants. J. Infect. Dis. 167, 627–632. doi: 10.1093/
infdis/167.3.627
Bliven, K. A., and Maurelli, A. T. (2012). Antivirulence genes: insights into
pathogen evolution through gene loss. Infect. Immun. 80, 4061–4070.
doi: 10.1128/IAI.00740-12
Buchrieser, C., Glaser, P., Rusniok, C., Nedjari, H., D’Hauteville, H., Kunst, F.,
et al. (2000). The virulence plasmid pWR100 and the repertoire of proteins
secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol.
38, 760–771. doi: 10.1046/j.1365-2958.2000.02179.x
Campbell-Valois, F.-X., Sachse, M., Sansonetti, P. J., and Parsot, C. (2015). Escape
of actively secreting Shigella flexneri from ATG8/LC3-positive vacuoles formed
during cell-to-cell spread is facilitated by IcsB and VirA. mBio 6:e02567-14.
doi: 10.1128/mBio.02567-14
Campilongo, R., Di Martino, M. L., Marcocci, L., Pietrangeli, P., Leuzzi, A.,
Grossi, M., et al. (2014). Molecular and functional profiling of the polyamine
content in enteroinvasive E. coli: looking into the gap between commensal
E. coli and harmful Shigella. PLOS ONE 9:e106589. doi: 10.1371/journal.pone.
0106589
Casalino, M., Latella, M. C., Prosseda, G., Ceccarini, P., Grimont, F., and
Colonna, B. (2005). Molecular evolution of the lysine decarboxylase-defective
phenotype in Shigella sonnei. Int. J. Med. Microbiol. 294, 503–512. doi: 10.1016/
j.ijmm.2004.11.001
Casalino, M., Latella, M. C., Prosseda, G., and Colonna, B. (2003). CadC is the
preferential target of a convergent evolution driving enteroinvasive Escherichia
coli toward a lysine decarboxylase-defective phenotype. Infect. Immun. 71,
5472–5479. doi: 10.1128/IAI.71.10.5472-5479.2003
Casalino, M., Prosseda, G., Barbagallo, M., Iacobino, A., Ceccarini, P., Carmela
Latella, M., et al. (2010). Interference of the CadC regulator in the arginine-
dependent acid resistance system of Shigella and enteroinvasive E. coli. Int. J.
Med. Microbiol. 300, 289–295. doi: 10.1016/j.ijmm.2009.10.008
Chatterjee, B. D., and Sanyal, S. N. (1984). Is it all shigellosis? Lancet 2, 574.
doi: 10.1016/S0140-6736(84)90783-9
Cheasty, T., and Rowe, B. (1983). Antigenic relationships between the
enteroinvasive Escherichia coli O antigens O28ac, O112ac, O124, O136, O143,
O144, O152, and O164 and Shigella O antigens. J. Clin. Microbiol. 17,
681–684.
Colonna, B., Casalino, M., Fradiani, P. A., Zagaglia, C., Naitza, S., Leoni, L.,
et al. (1995). H-NS regulation of virulence gene expression in enteroinvasive
Escherichia coli harboring the virulence plasmid integrated into the host
chromosome. J. Bacteriol. 177, 4703–4712. doi: 10.1128/jb.177.16.4703-4712.
1995
Croxen, M. A., and Finlay, B. B. (2009). Molecular mechanisms of Escherichia
coli pathogenicity. Nat. Rev. Microbiol. 8, 26–38. doi: 10.1038/nrmicro
2265
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., and Finlay,
B. B. (2013). Recent advances in understanding enteric pathogenic Escherichia
coli. Clin. Microbiol. Rev. 26, 822–880. doi: 10.1128/CMR.00022-13
Frontiers in Microbiology | www.frontiersin.org 9 December 2017 | Volume 8 | Article 2390
fmicb-08-02390 December 4, 2017 Time: 17:51 # 10
Pasqua et al. Evolution of Enteroinvasive E. coli
Dagberg, B., and Uhlin, B. E. (1992). Regulation of virulence-associated
plasmid genes in enteroinvasive Escherichia coli. J. Bacteriol. 174, 7606–7612.
doi: 10.1128/jb.174.23.7606-7612.1992
Di Martino, M. L., Campilongo, R., Casalino, M., Micheli, G., Colonna, B.,
and Prosseda, G. (2013a). Polyamines: emerging players in bacteria-host
interactions. Int. J. Med. Microbiol. 303, 484–491. doi: 10.1016/j.ijmm.2013.
06.008
Di Martino, M. L., Falconi, M., Micheli, G., Colonna, B., and Prosseda, G. (2016a).
The multifaceted activity of the VirF regulatory protein in the Shigella lifestyle.
Front. Mol. Biosci. 3:61. doi: 10.3389/fmolb.2016.00061
Di Martino, M. L., Fioravanti, R., Barbabella, G., Prosseda, G., Colonna, B., and
Casalino, M. (2013b). Molecular evolution of the nicotinic acid requirement
within the Shigella/EIEC pathotype. Int. J. Med. Microbiol. 303, 651–661.
doi: 10.1016/j.ijmm.2013.09.007
Di Martino, M. L., Romilly, C., Wagner, E. G. H., Colonna, B., and Prosseda, G.
(2016b). One gene and two proteins: a leaderless mRNA supports the
translation of a shorter form of the Shigella VirF regulator. mBio 7:e01860-16.
doi: 10.1128/mBio.01860-16
Dobrindt, U., Chowdary, M. G., Krumbholz, G., and Hacker, J. (2010). Genome
dynamics and its impact on evolution of Escherichia coli. Med. Microbiol.
Immunol. 199, 145–154. doi: 10.1007/s00430-010-0161-2
Dong, N., Zhu, Y., Lu, Q., Hu, L., Zheng, Y., and Shao, F. (2012). Structurally
distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to
counteract host defenses. Cell 150, 1029–1041. doi: 10.1016/j.cell.2012.06.050
Dorman, C. J. (2004). H-NS: a universal regulator for a dynamic genome. Nat. Rev.
Microbiol. 2, 391–400. doi: 10.1038/nrmicro883
DuPont, H. L., Formal, S. B., Hornick, R. B., Snyder, M. J., Libonati, J. P., Sheahan,
D. G., et al. (1971). Pathogenesis of Escherichia coli diarrhea. N. Engl. J. Med.
285, 1–9. doi: 10.1056/NEJM197107012850101
Echeverria, P., Sethabutr, O., Serichantalergs, O., Lexomboon, U., and Tamura, K.
(1992). Shigella and enteroinvasive Escherichia coli infections in households of
children with dysentery in Bangkok. J. Infect. Dis. 165, 144–147. doi: 10.1093/
infdis/165.1.144
Edwards, P. R., and Ewing, W. H. (1986). Edwards and Ewing’s Identification of
Enterobacteriaceae, 4th Edn. New York, NY: Elsvier Science.
Escher, M., Scavia, G., Morabito, S., Tozzoli, R., Maugliani, A., Cantoni, S., et al.
(2014). A severe foodborne outbreak of diarrhoea linked to a canteen in Italy
caused by enteroinvasive Escherichia coli, an uncommon agent. Epidemiol.
Infect. 142, 2559–2566. doi: 10.1017/S0950268814000181
Escobar-Páramo, P., Giudicelli, C., Parsot, C., and Denamur, E. (2003). The
evolutionary history of Shigella and enteroinvasive Escherichia coli revised.
J. Mol. Evol. 57, 140–148. doi: 10.1007/s00239-003-2460-3
Ewing, W. H., and Gravatti, J. L. (1947). Shigella types encountered in the
mediterranean area. J. Bacteriol. 53, 191–195.
Farmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter,
G. P., Asbury, M. A., et al. (1985). Biochemical identification of new species
and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin.
Microbiol. 21, 46–76.
Faundez, G., Figueroa, G., Troncoso, M., and Cabello, F. C. (1988).
Characterization of enteroinvasive Escherichia coli strains isolated from
children with diarrhea in Chile. J. Clin. Microbiol. 26, 928–932.
Fernandez, I. M., Silva, M., Schuch, R., Walker, W. A., Siber, A. M., Maurelli,
A. T., et al. (2001). Cadaverine prevents the escape of Shigella flexneri
from the phagolysosome: a connection between bacterial dissemination and
neutrophil transepithelial signaling. J. Infect. Dis. 184, 743–753. doi: 10.1086/
323035
Formal, S. B., and Hornick, R. B. (1978). Invasive Escherichia coli. J. Infect. Dis. 137,
641–644. doi: 10.1093/infdis/137.5.641
Giangrossi, M., Prosseda, G., Tran, C. N., Brandi, A., Colonna, B., and Falconi, M.
(2010). A novel antisense RNA regulates at transcriptional level the virulence
gene icsA of Shigella flexneri. Nucleic Acids Res. 38, 3362–3375. doi: 10.1093/
nar/gkq025
Gomes, T. A., Toledo, M. R., Trabulsi, L. R., Wood, P. K., and Morris, J. G.
(1987). DNA probes for identification of enteroinvasive Escherichia coli. J. Clin.
Microbiol. 25, 2025–2027.
Gomes, T. A. T., Elias, W. P., Scaletsky, I. C. A., Guth, B. E. C., Rodrigues, J. F.,
Piazza, R. M. F., et al. (2016). Diarrheagenic Escherichia coli. Braz. J. Microbiol.
47, 3–30. doi: 10.1016/j.bjm.2016.10.015
Hale, T. L., Oaks, E. V., and Formal, S. B. (1985). Identification and antigenic
characterization of virulence-associated, plasmid-coded proteins of Shigella
spp. and enteroinvasive Escherichia coli. Infect. Immun. 50, 620–629.
Hale, T. L., Sansonetti, P. J., Schad, P. A., Austin, S., and Formal, S. B.
(1983). Characterization of virulence plasmids and plasmid-associated outer
membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli.
Infect. Immun. 40, 340–350.
Harris, J. R., Wachsmuth, I. K., Davis, B. R., and Cohen, M. L. (1982). High-
molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness.
Infect. Immun. 37, 1295–1298.
Hazen, T. H., Leonard, S. R., Lampel, K. A., Lacher, D. W., Maurelli, A. T., and
Rasko, D. A. (2016). Investigating the relatedness of enteroinvasive Escherichia
coli to other E. coli and Shigella isolates by using comparative genomics. Infect.
Immun. 84, 2362–2371. doi: 10.1128/IAI.00350-16
Johnson, T. J., and Nolan, L. K. (2009). Pathogenomics of the virulence plasmids
of Escherichia coli. Microbiol. Mol. Biol. Rev. 73, 750–774. doi: 10.1128/MMBR.
00015-09
Kaper, J. B., Nataro, J. P., and Mobley, H. L. T. (2004). Pathogenic Escherichia coli.
Nat. Rev. Microbiol. 2, 123–140. doi: 10.1038/nrmicro818
Killackey, S. A., Sorbara, M. T., and Girardin, S. E. (2016). Cellular aspects of
Shigella pathogenesis: focus on the manipulation of host cell processes. Front.
Cell. Infect. Microbiol. 6:38. doi: 10.3389/fcimb.2016.00038
Kim, D. W., Lenzen, G., Page, A.-L., Legrain, P., Sansonetti, P. J., and Parsot, C.
(2005). The Shigella flexneri effector OspG interferes with innate immune
responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci.
U.S.A. 102, 14046–14051. doi: 10.1073/pnas.0504466102
Kopecko, D. J., Baron, L. S., and Buysse, J. (1985). Genetic determinants of
virulence in Shigella and dysenteric strains of Escherichia coli: their involvement
in the pathogenesis of dysentery. Curr. Top. Microbiol. Immunol. 118, 71–95.
doi: 10.1007/978-3-642-70586-1_5
Lan, R., Alles, M. C., Donohoe, K., Martinez, M. B., and Reeves, P. R. (2004).
Molecular evolutionary relationships of enteroinvasive Escherichia coli and
Shigella spp. Infect. Immun. 72, 5080–5088. doi: 10.1128/IAI.72.9.5080-5088.
2004
Lan, R., Lumb, B., Ryan, D., and Reeves, P. R. (2001). Molecular evolution of large
virulence plasmid in Shigella clones and enteroinvasive Escherichia coli. Infect.
Immun. 69, 6303–6309. doi: 10.1128/IAI.69.10.6303-6309.2001
Lan, R., and Reeves, P. R. (2002). Escherichia coli in disguise: molecular origins of
Shigella. Microbes Infect. 4, 1125–1132. doi: 10.1016/S1286-4579(02)01637-4
Leuzzi, A., Di Martino, M. L., Campilongo, R., Falconi, M., Barbagallo, M.,
Marcocci, L., et al. (2015). Multifactor regulation of the MdtJI polyamine
transporter in Shigella. PLOS ONE 10:e0136744. doi: 10.1371/journal.pone.
0136744
Leuzzi, A., Grossi, M., Di Martino, M. L., Pasqua, M., Micheli, G., Colonna, B.,
et al. (2017). Role of the SRRz/Rz1 lambdoid lysis cassette in the pathoadaptive
evolution of Shigella. Int. J. Med. Microbiol. 307, 268–275. doi: 10.1016/j.ijmm.
2017.03.002
Levine, M. M., Ferreccio, C., Prado, V., Cayazzo, M., Abrego, P., Martinez, J.,
et al. (1993). Epidemiologic studies of Escherichia coli diarrheal infections
in a low socioeconomic level peri-urban community in Santiago. Chile.
Am. J. Epidemiol. 138, 849–869. doi: 10.1093/oxfordjournals.aje.a1
16788
Makino, S., Sasakawa, C., and Yoshikawa, M. (1988). Genetic relatedness of
the basic replicon of the virulence plasmid in shigellae and enteroinvasive
Escherichia coli. Microb. Pathog. 5, 267–274. doi: 10.1016/0882-4010(88)
90099-X
Manolov, D. G. (1959). A new type of the genus Shigella –“Shigella 13”. J. Hyg.
Epidemiol. Microbiol. Immunol. 3, 184–190.
Marier, R., Wells, J., Swanson, R., Callahan, W., and Mehlman, I. (1973). An
outbreak of enteropathogenic Escherichia coli foodborne disease traced to
imported French cheese. Lancet 302, 1376–1378. doi: 10.1016/S0140-6736(73)
93335-7
Matsushita, S., Yamada, S., Kai, A., and Kudoh, Y. (1993). Invasive strains
of Escherichia coli belonging to serotype O121:NM. J. Clin. Microbiol. 31,
3034–3035.
Mattock, E., and Blocker, A. J. (2017). How do the virulence factors of Shigella work
together to cause disease? Front. Cell. Infect. Microbiol. 7:64. doi: 10.3389/fcimb.
2017.00064
Frontiers in Microbiology | www.frontiersin.org 10 December 2017 | Volume 8 | Article 2390
fmicb-08-02390 December 4, 2017 Time: 17:51 # 11
Pasqua et al. Evolution of Enteroinvasive E. coli
Michelacci, V., Prosseda, G., Maugliani, A., Tozzoli, R., Sanchez, S., Herrera-
León, S., et al. (2016). Characterization of an emergent clone of enteroinvasive
Escherichia coli circulating in Europe. Clin. Microbiol. Infect. 22, 287.e11–
287.e19. doi: 10.1016/j.cmi.2015.10.025
Moreno, A. C. R., Ferreira, L. G., and Martinez, M. B. (2009). Enteroinvasive
Escherichia coli vs. Shigella flexneri: how different patterns of gene expression
affect virulence. FEMS Microbiol. Lett. 301, 156–163. doi: 10.1111/j.1574-6968.
2009.01815.x
Nakata, N., Tobe, T., Fukuda, I., Suzuki, T., Komatsu, K., Yoshikawa, M., et al.
(1993). The absence of a surface protease, OmpT, determines the intercellular
spreading ability of Shigella: the relationship between the ompT and kcpA loci.
Mol. Microbiol. 9, 459–468. doi: 10.1111/j.1365-2958.1993.tb01707.x
Newitt, S., MacGregor, V., Robbins, V., Bayliss, L., Chattaway, M. A., Dallman, T.,
et al. (2016). Two linked enteroinvasive Escherichia coli outbreaks, Nottingham,
UK, June 2014. Emerg. Infect. Dis. 22, 1178–1184. doi: 10.3201/eid2207.152080
O’Brien, A. D., Gentry, M. K., Thompson, M. R., Doctor, B. P., Gemski, P.,
and Formal, S. B. (1979). Shigellosis and Escherichia coli diarrhea: relative
importance of invasive and toxigenic mechanisms. Am. J. Clin. Nutr. 32,
229–233.
Ogawa, M., Yoshimori, T., Suzuki, T., Sagara, H., Mizushima, N., and Sasakawa, C.
(2005). Escape of intracellular Shigella from autophagy. Science 307, 727–731.
doi: 10.1126/science.1106036
Orskov, I., Wachsmuth, I. K., Taylor, D. N., Echeverria, P., Rowe, B., Sakazaki, R.,
et al. (1991). Two new Escherichia coli O groups: O172 from “Shiga-like” toxin
II-producing strains (EHEC) and O173 from enteroinvasive E. coli (EIEC).
APMIS 99, 30–32. doi: 10.1111/j.1699-0463.1991.tb05114.x
Parsot, C. (2005). Shigella spp. and enteroinvasive Escherichia coli pathogenicity
factors. FEMS Microbiol. Lett. 252, 11–18. doi: 10.1016/j.femsle.2005.08.046
Pavlovic, M., Luze, A., Konrad, R., Berger, A., Sing, A., Busch, U., et al. (2011).
Development of a duplex real-time PCR for differentiation between E. coli and
Shigella spp. J. Appl. Microbiol. 110, 1245–1251. doi: 10.1111/j.1365-2672.2011.
04973.x
Pettengill, E. A., Pettengill, J. B., and Binet, R. (2015). Phylogenetic analyses of
Shigella and enteroinvasive Escherichia coli for the identification of molecular
epidemiological markers: whole-genome comparative analysis does not support
distinct genera designation. Front. Microbiol. 6:1573. doi: 10.3389/fmicb.2015.
01573
Pettengill, E. A., Pettengill, J. B., and Binet, R. (2016). Phylogenetic analyses of
Shigella and enteroinvasive Escherichia coli for the identification of molecular
epidemiological markers: whole-genome comparative analysis does not support
distinct genera designation. Front. Microbiol. 6:1573. doi: 10.3389/fmicb.2015.
01573
Prosseda, G., Carmela Latella, M., Barbagallo, M., Nicoletti, M., Al Kassas, R.,
Casalino, M., et al. (2007). The two-faced role of cad genes in the virulence of
pathogenic Escherichia coli. Res. Microbiol. 158, 487–493. doi: 10.1016/j.resmic.
2007.05.001
Prosseda, G., Di Martino, M. L., Campilongo, R., Fioravanti, R., Micheli, G.,
Casalino, M., et al. (2012). Shedding of genes that interfere with the pathogenic
lifestyle: the Shigella model. Res. Microbiol. 163, 399–406. doi: 10.1016/j.resmic.
2012.07.004
Prosseda, G., Falconi, M., Giangrossi, M., Gualerzi, C. O., Micheli, G., and
Colonna, B. (2004). The virF promoter in Shigella: more than just a curved
DNA stretch. Mol. Microbiol. 51, 523–537. doi: 10.1046/j.1365-2958.2003.
03848.x
Prosseda, G., Falconi, M., Nicoletti, M., Casalino, M., Micheli, G., and Colonna, B.
(2002). Histone-like proteins and the Shigella invasivity regulon. Res. Microbiol.
153, 461–468. doi: 10.1016/S0923-2508(02)01346-3
Prosseda, G., Latella, M. C., Casalino, M., Nicoletti, M., Michienzi, S., and
Colonna, B. (2006). Plasticity of the P junc promoter of ISEc11, a new insertion
sequence of the IS1111 family. J. Bacteriol. 188, 4681–4689. doi: 10.1128/JB.
00332-06
Prunier, A.-L., Schuch, R., Fernandez, R. E., Mumy, K. L., Kohler, H., McCormick,
B. A., et al. (2007). nadA and nadB of Shigella flexneri 5a are antivirulence
loci responsible for the synthesis of quinolinate, a small molecule inhibitor of
Shigella pathogenicity. Microbiology 153, 2363–2372. doi: 10.1099/mic.0.2007/
006916-0
Pupo, G. M., Lan, R., and Reeves, P. R. (2000). Multiple independent origins of
Shigella clones of Escherichia coli and convergent evolution of many of their
characteristics. Proc. Natl. Acad. Sci. U.S.A. 97, 10567–10572. doi: 10.1073/pnas.
180094797
Rasko, D. A., Rosovitz, M. J., Myers, G. S. A., Mongodin, E. F., Fricke, W. F.,
Gajer, P., et al. (2008). The pangenome structure of Escherichia coli: comparative
genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 190,
6881–6893. doi: 10.1128/JB.00619-08
Reiterer, V., Grossniklaus, L., Tschon, T., Kasper, C. A., Sorg, I., and
Arrieumerlou, C. (2011). Shigella flexneri type III secreted effector OspF
reveals new crosstalks of proinflammatory signaling pathways during bacterial
infection. Cell. Signal. 23, 1188–1196. doi: 10.1016/j.cellsig.2011.03.006
Rowe, B., Gross, R. J., and Woodroof, D. P. (1977). Proposal to recognise seroovar
145/46 (synonyms: 147, Shigella 13, Shigella sofia, and Shigella manolovii)
as a New Escherichia coli O group, O164. Int. J. Syst. Bacteriol. 27, 15–18.
doi: 10.1099/00207713-27-1-15
Sahl, J. W., Morris, C. R., Emberger, J., Fraser, C. M., Ochieng, J. B., Juma, J.,
et al. (2015). Defining the phylogenomics of Shigella species: a pathway to
diagnostics. J. Clin. Microbiol. 53, 951–960. doi: 10.1128/JCM.03527-14
Sakazaki, R., Tamura, K., and Saito, M. (1967). Enteropathogenic Escherichia coli
associated with diarrhea in children and adults. Jpn. J. Med. Sci. Biol. 20,
387–399. doi: 10.7883/yoken1952.20.387
Sanchez-Villamil, J., Tapia-Pastrana, G., and Navarro-Garcia, F. (2016). Pathogenic
lifestyles of E. coli pathotypes in a standardized epithelial cell model influence
inflammatory signaling pathways and cytokines secretion. Front. Cell. Infect.
Microbiol. 6:120. doi: 10.3389/fcimb.2016.00120
Sansonetti, P. J., Hale, T. L., Dammin, G. J., Kapfer, C., Collins, H. H., and
Formal, S. B. (1983). Alterations in the pathogenicity of Escherichia coli K-12
after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect.
Immun. 39, 1392–1402.
Sansonetti, P. J., Kopecko, D. J., and Formal, S. B. (1982). Involvement of
a plasmid in the invasive ability of Shigella flexneri. Infect. Immun. 35,
852–860.
Schroeder, G. N., and Hilbi, H. (2008). Molecular pathogenesis of Shigella spp.:
controlling host cell signaling, invasion, and death by type III secretion. Clin.
Microbiol. Rev. 21, 134–156. doi: 10.1128/CMR.00032-07
Scribano, D., Petrucca, A., Pompili, M., Ambrosi, C., Bruni, E., Zagaglia, C., et al.
(2014). Polar localization of PhoN2, a periplasmic virulence-associated factor of
Shigella flexneri, is required for proper IcsA exposition at the old bacterial pole.
PLOS ONE 9:e90230. doi: 10.1371/journal.pone.0090230
Silva, R. M., Toledo, M. R., and Trabulsi, L. R. (1980). Biochemical and cultural
characteristics of invasive Escherichia coli. J. Clin. Microbiol. 11, 441–444.
Small, P. L., and Falkow, S. (1988). Identification of regions on a 230-kilobase
plasmid from enteroinvasive Escherichia coli that are required for entry into
HEp-2 cells. Infect. Immun. 56, 225–229.
Svenungsson, B., Lagergren, A., Ekwall, E., Evengård, B., Hedlund, K. O.,
Kärnell, A., et al. (2000). Enteropathogens in adult patients with diarrhea and
healthy control subjects: a 1-year prospective study in a Swedish clinic for
infectious diseases. Clin. Infect. Dis. 30, 770–778. doi: 10.1086/313770
Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation.
Cell 140, 805–820. doi: 10.1016/j.cell.2010.01.022
Taylor, D. N., Echeverria, P., Sethabutr, O., Pitarangsi, C., Leksomboon, U.,
Blacklow, N. R., et al. (1988). Clinical and microbiologic features of Shigella
and enteroinvasive Escherichia coli infections detected by DNA hybridization.
J. Clin. Microbiol. 26, 1362–1366.
Toledo, M. R., and Trabulsi, L. R. (1983). Correlation between biochemical and
serological characteristics of Escherichia coli and results of the Serény test. J.
Clin. Microbiol. 17, 419–421.
Touchon, M., Hoede, C., Tenaillon, O., Barbe, V., Baeriswyl, S., Bidet, P., et al.
(2009). Organised genome dynamics in the Escherichia coli species results in
highly diverse adaptive paths. PLOS Genet. 5:e1000344. doi: 10.1371/journal.
pgen.1000344
Tozzoli, R., and Scheutz, F. (2014). “Diarrheagenic Escherichia coli infections in
humans,” in Pathogenic Escherichia coli: Molecular and Cellular Microbiology,
ed. S. Morabito (Norfolk: Caister Academic Press).
Trabulsi, L. R., Fernandes, M. R., and Zuliani, M. E. (1967). New intestinal bacteria
pathogenic to man. Rev. Inst. Med. Trop. Sao Paulo 9, 31–39.
Tran, C. N., Giangrossi, M., Prosseda, G., Brandi, A., Di Martino, M. L.,
Colonna, B., et al. (2011). A multifactor regulatory circuit involving H-NS,
VirF and an antisense RNA modulates transcription of the virulence gene
Frontiers in Microbiology | www.frontiersin.org 11 December 2017 | Volume 8 | Article 2390
fmicb-08-02390 December 4, 2017 Time: 17:51 # 12
Pasqua et al. Evolution of Enteroinvasive E. coli
icsA of Shigella flexneri. Nucleic Acids Res. 39, 8122–8134. doi: 10.1093/nar/
gkr521
Turner, S. A., Luck, S. N., Sakellaris, H., Rajakumar, K., and Adler, B. (2003).
Molecular epidemiology of the SRL pathogenicity island. Antimicrob. Agents
Chemother. 47, 727–734. doi: 10.1128/AAC.47.2.727-734.2003
van den Beld, M. J. C., and Reubsaet, F. A. G. (2012). Differentiation between
Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli.
Eur. J. Clin. Microbiol. Infect. Dis. 31, 899–904. doi: 10.1007/s10096-011-1395-7
van Elsas, J. D., Semenov, A. V., Costa, R., and Trevors, J. T. (2011). Survival of
Escherichia coli in the environment: fundamental and public health aspects.
ISME J. 5, 173–183. doi: 10.1038/ismej.2010.80
Venkatesan, M. M., Goldberg, M. B., Rose, D. J., Grotbeck, E. J., Burland, V.,
and Blattner, F. R. (2001). Complete DNA sequence and analysis of the
large virulence plasmid of Shigella flexneri. Infect. Immun. 69, 3271–3285.
doi: 10.1128/IAI.69.5.3271-3285.2001
Vieira, N., Bates, S. J., Solberg, O. D., Ponce, K., Howsmon, R., Cevallos, W., et al.
(2007). High prevalence of enteroinvasive Escherichia coli isolated in a remote
region of northern coastal Ecuador. Am. J. Trop. Med. Hyg. 76, 528–533.
Voeroes, S., Redey, B., and Csizmazia, F. (1964). Antigenic structure of a new
enteropathogenic E. coli strain. Acta Microbiol. Acad. Sci. Hung. 11, 125–129.
Wanger, A. R., Murray, B. E., Echeverria, P., Mathewson, J. J., and DuPont, H. L.
(1988). Enteroinvasive Escherichia coli in travelers with diarrhea. J. Infect. Dis.
158, 640–642. doi: 10.1093/infdis/158.3.640
Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L. H., et al. (2006). Sex
and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol.
60, 1136–1151. doi: 10.1111/j.1365-2958.2006.05172.x
Zagaglia, C., Casalino, M., Colonna, B., Conti, C., Calconi, A., and Nicoletti, M.
(1991). Virulence plasmids of enteroinvasive Escherichia coli and Shigella
flexneri integrate into a specific site on the host chromosome: integration
greatly reduces expression of plasmid-carried virulence genes. Infect. Immun.
59, 792–799.
Zuo, G., Xu, Z., and Hao, B. (2013). Shigella strains are not clones
of Escherichia coli but sister species in the genus Escherichia.
Genomics Proteomics Bioinformatics 11, 61–65. doi: 10.1016/j.gpb.2012.
11.002
Zurawski, D. V., Mumy, K. L., Faherty, C. S., McCormick, B. A., and Maurelli, A. T.
(2009). Shigella flexneri type III secretion system effectors OspB and OspF target
the nucleus to downregulate the host inflammatory response via interactions
with retinoblastoma protein. Mol. Microbiol. 71, 350–368. doi: 10.1111/j.1365-
2958.2008.06524.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Pasqua, Michelacci, Di Martino, Tozzoli, Grossi, Colonna,
Morabito and Prosseda. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 12 December 2017 | Volume 8 | Article 2390
